Joimax recorded a nearly 30 percent increase in consolidated sales in 2017 compared to 2016.
Here are five highlights:
1. The company's sales have grown at a 35 percent compound annual growth rate since 2008.
2. Joimax has a footprint in 50 countries, focusing on Europe, Asia and the U.S.
3. The company credits the American Medical Association CPT code 62380 for endoscopic decompression of the lumbar spine, effective in January 2017, as driving its success in the U.S.
4. Joimax recently received approval for its Endovapor 2 Multi Radio Frequency System in Asia, allowing the company to market its portfolio of systems in China.
5. With the increasing focus on SI joint treatment, joimax is hopeful for its success with its MultiZYTE Facet and SI Joint Treatment Set offering.